USPTO 2015–2025 USPTO PatentsView US Corporation

Mevion Medical Systems, Inc.

USPTO PatentsView assignee record — 47 granted patents across 12 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).

47
Total patents granted
12
CPC technology areas
31.8
Avg claims per patent
-26%
5-year filing velocity

Portfolio overview

Mevion Medical Systems, Inc. has been granted 47 US utility patents between 2015 and 2025, placing Mevion Medical Systems, Inc. at rank #7,047 across all assignees tracked by PlainPatent. This portfolio spans 12 distinct Cooperative Patent Classification (CPC) subclasses, averaging 31.8 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Mevion Medical Systems, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 44.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 20 grants, compared with 27 in the 2015–2019 window — a -26% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Mevion Medical Systems, Inc.'s 31.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 12 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Mevion Medical Systems, Inc. against peers pursuing similar technology classes.

How does Mevion compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Mevion holds 47 patents — placing it at rank #7,047 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

USPTO utility patent grants by year · 2015–2025

0246810 20152016201720182019202020212022202320242025 2
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Mevion Medical Systems, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 8 17.0%
2016 2 4.3%
2017 7 14.9%
2018 4 8.5%
2019 6 12.8%
2020 7 14.9%
2021 2 4.3%
2022 3 6.4%
2023 3 6.4%
2024 3 6.4%
2025 2 4.3%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Declining

Where it ranks

Overall rank by patents

#7,047

Across all tracked assignees

Innovation Score

44.6 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Mevion Medical Systems, Inc. hold?
Mevion Medical Systems, Inc. holds 47 US granted patents filed between 2015 and 2025, spanning 12 technology areas.
What is Mevion Medical Systems, Inc.'s Innovation Score?
Mevion Medical Systems, Inc. has an Innovation Score of 44.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Mevion Medical Systems, Inc. focus on?
Mevion Medical Systems, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY) with 41 patents. The company has filed patents in 12 CPC subclasses total.
Is Mevion Medical Systems, Inc.'s patent filing rate increasing or decreasing?
Mevion Medical Systems, Inc.'s recent filing velocity is -26% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Mevion Medical Systems, Inc.'s patents?
Mevion Medical Systems, Inc.'s patents average 31.8 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Mevion Medical Systems, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope